Epilepsy burden shifts as aging and inequality reshape care

A new review of global and Chinese epilepsy trends finds that deaths have fallen, but disability remains concentrated in low-income countries and care gaps persist in China. The study points to aging populations, stroke-related epilepsy and weak primary care as the next pressure points for diagnosis, treatment and long-term management.

Why it matters: - Epilepsy is no longer just a mortality story. The disease burden is shifting toward disability, aging, and unequal access to care. - About 51.7 million people worldwide live with active epilepsy. - Low- and lower-middle-income countries account for 87.9% of epilepsy-associated disability-adjusted life years, showing where the heaviest burden falls. - In China, about 9 million to 10 million people have epilepsy, so the country’s care gaps affect a very large patient population.

What happened: - Researchers led by Professor Xin Shi of China Medical University and Professor Lei Chen of West China Hospital reviewed global and Chinese epilepsy trends using GBD 2021 data, provincial evidence, and health-system assessments. - The study, published online July 27, 2026, in Neuroprotection, examined epilepsy through biological, health-system, and social-determinant lenses. - The review covers trends from 1990 to 2021.

The details: - Global epilepsy cases rose in absolute number over three decades as population growth and aging increased the total population at risk. - In China, age-standardized mortality for idiopathic epilepsy fell 56.6% from 1990 to 2021. - China’s age-standardized disability-adjusted life year rate fell 43.2% over the same period. - The disease pattern is shifting toward middle-aged and older adults. - Stroke and dementia are becoming important structural drivers of epilepsy. - Mortality in western Chinese provinces is about nine times higher than in eastern provinces. - Rural treatment gaps are 60% to 90%. - More than 90% of epilepsy centers are in tertiary hospitals, mostly in eastern China. - By 2025, China’s epilepsy center network included 526 centers across tertiary, secondary, and primary levels. - About 89% of patients report feeling stigma. - People with rare epilepsy syndromes can face diagnostic delays, treatment resistance, and household burdens. - The paper cites the World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031 as the policy frame for next-step action. - The DOI for the paper is 10.1002/nep3.70053.

Between the lines: - The findings suggest that better survival does not automatically mean better access or better outcomes. - Aging populations and more stroke-related epilepsy are likely to increase demand for neurology, rehabilitation, and long-term follow-up. - The biggest barriers now appear to be system design, affordability, referral pathways, and stigma rather than diagnosis alone. - China’s expansion of epilepsy centers may help, but only if services reach primary care and adapt to local capacity.

What's next: - The authors call for epilepsy prevention to be integrated with stroke, injury, and perinatal programs. - They also want stronger risk identification after stroke and severe traumatic brain injury. - The review recommends better management of psychiatric and cognitive comorbidities. - Telemedicine and artificial intelligence could help with remote EEG interpretation and diagnosis. - The authors say health systems need stronger primary care, better referrals, financial protection, and anti-discrimination measures to improve long-term outcomes.

The bottom line: - Epilepsy mortality has improved, but the burden is increasingly shaped by inequality and aging. - The next phase of progress depends on making care continuous, affordable, and reachable outside major hospitals.